BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
17 results:

  • 1. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study.
    Yang J; Zhou H; Li H; Zhao F; Tong K
    BMC Cancer; 2024 Feb; 24(1):193. PubMed ID: 38347528
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
    Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
    ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
    J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]    [Full Text] [Related]  

  • 6. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
    Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
    JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
    Nakachi K; Ikeda M; Konishi M; Nomura S; Katayama H; Kataoka T; Todaka A; Yanagimoto H; Morinaga S; Kobayashi S; Shimada K; Takahashi Y; Nakagohri T; Gotoh K; Kamata K; Shimizu Y; Ueno M; Ishii H; Okusaka T; Furuse J;
    Lancet; 2023 Jan; 401(10372):195-203. PubMed ID: 36681415
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adenosquamous cancer of the pancreas: A multicenter retrospective study.
    Ramia-Angel JM; Jaén-Torrejimeno I; Serrablo-Requejo A; Rodríguez-Laiz GP; López-Guerra D; Abadía-Forcén T; Alenda C; Serradilla-Martín M; Blanco-Fernández G
    Gastroenterol Hepatol; 2022; 45(7):543-551. PubMed ID: 34952130
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Day of surgery and mortality after pancreatoduodenectomy: A retrospective analysis of 29 270 surgical cases of pancreatic head cancer from Japan.
    Uemura S; Endo H; Ichihara N; Miyata H; Maeda H; Hasegawa H; Kamiya K; Kakeji Y; Yoshida K; Yasuyuki S; Yamaue H; Yamamoto M; Kitagawa Y; Hanazaki K
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):778-784. PubMed ID: 34496150
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Donafenib Versus Sorafenib in First-Line treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
    Qin S; Bi F; Gu S; Bai Y; Chen Z; Wang Z; Ying J; Lu Y; Meng Z; Pan H; Yang P; Zhang H; Chen X; Xu A; Cui C; Zhu B; Wu J; Xin X; Wang J; Shan J; Chen J; Zheng Z; Xu L; Wen X; You Z; Ren Z; Liu X; Qiu M; Wu L; Chen F
    J Clin Oncol; 2021 Sep; 39(27):3002-3011. PubMed ID: 34185551
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
    Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
    Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
    Zhu AX; Nipp RD; Finn RS; Galle PR; Llovet JM; Blanc JF; Okusaka T; Chau I; Cella D; Girvan A; Gable J; Bowman L; Wang C; Hsu Y; Abada PB; Kudo M
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817068
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria.
    Kobayashi Y; Kiya Y; Nishioka Y; Hashimoto M; Shindoh J
    HPB (Oxford); 2020 Feb; 22(2):258-264. PubMed ID: 31326264
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel Three-Step Approach for Secure Splenectomy During Laparoscopic Total Gastrectomy for Gastric cancer.
    Matsubara H; Kinjo Y; Fukugaki A; Iwamoto M; Ohara K; Ishino Y; Ochi S; Matsumoto T; Matsushita T; Satoh S
    J Gastrointest Surg; 2019 May; 23(5):1082-1083. PubMed ID: 30367398
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. No-touch pancreatectomy for invasive ductal carcinoma of the pancreas.
    Hirota M; Ogawa M
    JOP; 2014 May; 15(3):243-9. PubMed ID: 24865535
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.
    Lombard-Bohas C; Mitry E; O'Toole D; Louvet C; Pillon D; Cadiot G; Borson-Chazot F; Aparicio T; Ducreux M; Lecomte T; Etienne PL; Cacheux W; Legoux JL; Seitz JF; Ruszniewski P; Chayvialle JA; Rougier P;
    Neuroendocrinology; 2009; 89(2):217-22. PubMed ID: 18719344
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population.
    Sexe RB; Wade TP; Virgo KS; Johnson FE
    Cancer; 1996 Jan; 77(2):251-4. PubMed ID: 8625231
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.